Source: CURATED ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4085248
Disease: OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO
OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO 		0.300 GermlineCausalMutation phenotype ORPHANET Osteofibrous dysplasia: clinicopathologic study of 80 cases. 8276381 1993
CUI: C1306837
Disease: Papillary Renal Cell Carcinoma
Papillary Renal Cell Carcinoma 		0.800 Biomarker disease CLINGEN Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. 9140397 1997
CUI: C1336839
Disease: Type 1 Papillary Renal Cell Carcinoma
Type 1 Papillary Renal Cell Carcinoma 		0.320 GeneticVariation disease UNIPROT Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. 9140397 1997
CUI: C1336078
Disease: Papillary renal cell carcinoma, sporadic
Papillary renal cell carcinoma, sporadic 		0.300 Biomarker disease CLINGEN Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. 9140397 1997
CUI: C1836723
Disease: Tibia, Bowing of, with Pseudarthrosis and Pectus Excavatum
Tibia, Bowing of, with Pseudarthrosis and Pectus Excavatum 		0.300 GermlineCausalMutation disease ORPHANET Bilateral osteofibrous dysplasia: a report of two cases and review of the literature. 9234973 1997
CUI: C4085248
Disease: OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO
OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO 		0.300 GermlineCausalMutation phenotype ORPHANET Bilateral osteofibrous dysplasia: a report of two cases and review of the literature. 9234973 1997
CUI: C1306837
Disease: Papillary Renal Cell Carcinoma
Papillary Renal Cell Carcinoma 		0.800 Biomarker disease CLINGEN Activating mutations for the met tyrosine kinase receptor in human cancer. 9326629 1997
CUI: C1336078
Disease: Papillary renal cell carcinoma, sporadic
Papillary renal cell carcinoma, sporadic 		0.300 Biomarker disease CLINGEN Activating mutations for the met tyrosine kinase receptor in human cancer. 9326629 1997
CUI: C1336839
Disease: Type 1 Papillary Renal Cell Carcinoma
Type 1 Papillary Renal Cell Carcinoma 		0.320 GeneticVariation disease UNIPROT Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. 9563489 1998
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma 		1.000 GeneticVariation disease UNIPROT Our results indicate that mutations of the tyrosine kinase domain of the MET gene may be involved in the acceleration of the carcinogenesis in childhood HCC. 9927037 1999
CUI: C0279606
Disease: Childhood Hepatocellular Carcinoma
Childhood Hepatocellular Carcinoma 		0.300 SomaticCausalMutation disease ORPHANET Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. 9927037 1999
CUI: C1336839
Disease: Type 1 Papillary Renal Cell Carcinoma
Type 1 Papillary Renal Cell Carcinoma 		0.320 GeneticVariation disease UNIPROT Novel mutations of the MET proto-oncogene in papillary renal carcinomas. 10327054 1999
CUI: C1336839
Disease: Type 1 Papillary Renal Cell Carcinoma
Type 1 Papillary Renal Cell Carcinoma 		0.320 GeneticVariation disease UNIPROT Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. 10417759 1999
CUI: C1306837
Disease: Papillary Renal Cell Carcinoma
Papillary Renal Cell Carcinoma 		0.800 Biomarker disease CLINGEN Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. 10433944 1999
CUI: C1336839
Disease: Type 1 Papillary Renal Cell Carcinoma
Type 1 Papillary Renal Cell Carcinoma 		0.320 GeneticVariation disease UNIPROT Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. 10433944 1999
CUI: C1336078
Disease: Papillary renal cell carcinoma, sporadic
Papillary renal cell carcinoma, sporadic 		0.300 Biomarker disease CLINGEN Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. 10433944 1999
CUI: C0004114
Disease: Astrocytoma
Astrocytoma 		0.340 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001
CUI: C0334579
Disease: Anaplastic astrocytoma
Anaplastic astrocytoma 		0.320 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001
CUI: C0205768
Disease: Subependymal Giant Cell Astrocytoma
Subependymal Giant Cell Astrocytoma 		0.300 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001
CUI: C0280783
Disease: Juvenile Pilocytic Astrocytoma
Juvenile Pilocytic Astrocytoma 		0.300 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001
CUI: C0280785
Disease: Diffuse Astrocytoma
Diffuse Astrocytoma 		0.300 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001
CUI: C0334580
Disease: Protoplasmic astrocytoma
Protoplasmic astrocytoma 		0.300 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001
CUI: C0334581
Disease: Gemistocytic astrocytoma
Gemistocytic astrocytoma 		0.300 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001
CUI: C0334582
Disease: Fibrillary Astrocytoma
Fibrillary Astrocytoma 		0.300 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001
CUI: C0334583
Disease: Pilocytic Astrocytoma
Pilocytic Astrocytoma 		0.300 Biomarker disease CTD_human Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. 11223164 2001